Biggest News Aggregation in the World
๐Ÿ“ฐ Mark Berger News

Page 5 - Mark Berger News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mark Berger. Real-time updates on events, politics, business and more.

Genprex Inc unveils groundbreaking data from primate study on its novel gene therapy to treat Type 1 diabetes at International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2023), in Berlin

Genprex, Inc. (NASDAQ:GNPX) has announced that data highlighting the potential of its gene therapy for Type 1 diabetes is being presented by its research...
University Of Pittsburg United States Rodney Varner George Gittes Mark Berger Ranjeet Kalsi

Genprex Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Gene Therapy to Treat Type 1 Diabetes at 16th Annual International Conference on Advanced Technologies & Treatment f

24.02.2023 - EQS-Media / 24.02.2023 / 15:26 CET/CEST Results show statistically significant decreases in insulin requirements, increases in c-peptide levels and improvements in glucose tolerance compared to baseline Disruptive gene therapy approach developed ...
Ari Zoldan Mark Berger Exchange Commission Genprex Inc Drug Administration Distribution Services

Genprex Inc says research collaborators at the University of Pittsburgh to present preclinical data highlighting potential of its gene therapy for Type 1 diabetes at Berlin conference

Genprex Inc. (NASDAQ:GNPX) has announced that its research collaborators at the University of Pittsburgh will present preclinical data highlighting the...
George Gittes Mark Berger Ranjeet Kalsi Division Of Pediatric Surgery Genprex Inc University Of Pittsburgh School Medicine

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...
United States Mark Berger Exchange Commission Genprex Inc Drug Administration Safety Review Committee

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science